Becker's Healthcare July 13, 2018
Morgan Haefner

U.S. antitrust regulators might not attempt to block CVS Health’s proposed $68 billion takeover of Aetna, according to Bloomberg, which cites a report by Reorg Research.

The report had positive effects on the companies’ shares, although Reorg Research did not disclose the origin of the information. CVS stock spiked 3.1 percent July 12, and Aetna shares increased...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Insurance, Mergers & Acquisitions / JV, Payer, Pharma, Provider, Retail care, Trends
In the Pipeline: LifeSpire of Virginia Announces $80M Renovation Plan; Oak Trace Completes Multiphase $112M Campus Redevelopment
Boston Scientific’s $3.7B Axonics buy tops list of medtech M&A in 2024
Digital health venture capital deals stagnate
Ascension continues selling spree
Acadia Executes 3 New Acquisitions, Fueling 2024 Growth Strategy

Share This Article